Literature DB >> 18676825

COOH-terminal binding protein regulates expression of the p16INK4A tumor suppressor and senescence in primary human cells.

Edmund A Mroz1, Abigail H Baird, William A Michaud, James W Rocco.   

Abstract

The p16/pocket-protein pathway sets a balance between tumor suppression and capacity for tissue regeneration. Understanding the upstream signaling pathway that turns on the expression of p16 is required both for knowing the tumorigenic stresses from which this pathway provides protection and for appreciating the selective pressure that leads to the loss of this pathway in most human tumors. We report that COOH-terminal binding protein (CtBP), a physiologically regulated transcriptional corepressor that dimerizes to hold together repressive complexes, regulates p16 expression in primary human fibroblasts and keratinocytes. Interfering with CtBP-mediated repression increased p16 expression and accelerated senescence. CtBP had little influence on the expression of the alternate product of the CDKN2A tumor-suppressor gene, p14(ARF). Loss of CtBP-mediated repression diminished the Polycomb-based epigenetic histone mark that is reported to favor silencing of p16 via DNA methylation. Enhancing CtBP-mediated repression by growing cells in low oxygen increased the association of CtBP with the p16 promoter, as assessed by chromatin immunoprecipitation, and reduced p16 expression. Stresses and stimuli that reduce CtBP-mediated repression are associated with increased p16 expression; therefore, CtBP may provide a common final target for regulating the balance among tumor suppression, regenerative capacity, and senescence.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18676825     DOI: 10.1158/0008-5472.CAN-08-1279

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  22 in total

1.  Epidermal growth factor receptor and mutant p53 expand an esophageal cellular subpopulation capable of epithelial-to-mesenchymal transition through ZEB transcription factors.

Authors:  Shinya Ohashi; Mitsuteru Natsuizaka; Gabrielle S Wong; Carmen Z Michaylira; Katharine D Grugan; Douglas B Stairs; Jiri Kalabis; Maria E Vega; Ross A Kalman; Momo Nakagawa; Andres J Klein-Szanto; Meenhard Herlyn; J Alan Diehl; Anil K Rustgi; Hiroshi Nakagawa
Journal:  Cancer Res       Date:  2010-04-27       Impact factor: 12.701

2.  CtBP1 interacts with Ikaros and modulates pituitary tumor cell survival and response to hypoxia.

Authors:  Katie Dorman; Zhongyi Shen; Caimei Yang; Shereen Ezzat; Sylvia L Asa
Journal:  Mol Endocrinol       Date:  2012-02-02

3.  Silencing of CtBP1 suppresses the migration in human glioma cells.

Authors:  Chengjin Zhao; Yifen Shen; Xuelei Tao; Jian Xu; Junjie Lu; Chao Liu; Zhiwei Xu; Qing Tang; Tao Tao; Xiubing Zhang
Journal:  J Mol Histol       Date:  2016-05-09       Impact factor: 2.611

4.  Human papillomavirus type 16 E7 oncoprotein upregulates the retinoic acid receptor-beta expression in cervical cancer cell lines and K14E7 transgenic mice.

Authors:  Jorge Gutiérrez; Enrique García-Villa; Rodolfo Ocadiz-Delgado; Enoc M Cortés-Malagón; Juan Vázquez; Alejandra Roman-Rosales; Elizabeth Alvarez-Rios; Haydar Celik; Marta C Romano; Aykut Üren; Paul F Lambert; Patricio Gariglio
Journal:  Mol Cell Biochem       Date:  2015-07-15       Impact factor: 3.396

5.  Prostate tumor growth is impaired by CtBP1 depletion in high-fat diet-fed mice.

Authors:  Cristian P Moiola; Paola De Luca; Florencia Zalazar; Javier Cotignola; Santiago A Rodríguez-Seguí; Kevin Gardner; Roberto Meiss; Pablo Vallecorsa; Omar Pignataro; Osvaldo Mazza; Elba S Vazquez; Adriana De Siervi
Journal:  Clin Cancer Res       Date:  2014-05-19       Impact factor: 12.531

Review 6.  Regulatory mechanisms of tumor suppressor P16(INK4A) and their relevance to cancer.

Authors:  Junan Li; Ming Jye Poi; Ming-Daw Tsai
Journal:  Biochemistry       Date:  2011-06-06       Impact factor: 3.162

7.  Epigenetic repression of p16(INK4A) by latent Epstein-Barr virus requires the interaction of EBNA3A and EBNA3C with CtBP.

Authors:  Lenka Skalska; Robert E White; Melanie Franz; Michaela Ruhmann; Martin J Allday
Journal:  PLoS Pathog       Date:  2010-06-10       Impact factor: 6.823

8.  Expression of CtBP family protein isoforms in breast cancer and their role in chemoresistance.

Authors:  Charles N Birts; Rachael Harding; Gehan Soosaipillai; Trisha Halder; Ali Azim-Araghi; Matthew Darley; Ramsey I Cutress; Adrian C Bateman; Jeremy P Blaydes
Journal:  Biol Cell       Date:  2010-01       Impact factor: 4.458

9.  The corepressor CTBP2 is a coactivator of retinoic acid receptor/retinoid X receptor in retinoic acid signaling.

Authors:  Prashanth Kumar Bajpe; Guus J J E Heynen; Lorenza Mittempergher; Wipawadee Grernrum; Iris A de Rink; Wouter Nijkamp; Roderick L Beijersbergen; Rene Bernards; Sidong Huang
Journal:  Mol Cell Biol       Date:  2013-06-17       Impact factor: 4.272

10.  Interaction of ZEB and histone deacetylase with the PLDLS-binding cleft region of monomeric C-terminal binding protein 2.

Authors:  Ling-Jun Zhao; M Kuppuswamy; S Vijayalingam; G Chinnadurai
Journal:  BMC Mol Biol       Date:  2009-09-15       Impact factor: 2.946

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.